Typical cMRI pattern as diagnostic clue for D‐bifunctional protein deficiency without apparent biochemical abnormalities in plasma
- 14 October 2010
- journal article
- case report
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 152A (11) , 2845-2849
Abstract
D‐bifunctional protein deficiency (DBPD) is an autosomal recessive disease caused by a defect in peroxisomal β‐oxidation. The majority of patients suffer from a severe neurological disease with neonatal hypotonia and seizures and die within the first 2 years of life. Few patients show milder clinical phenotypes with prolonged survival. The diagnosis relies on the clinical presentation, measurement of peroxisomal markers, including very long chain fatty acids (VLCFA) in plasma, followed by enzymatic studies in fibroblasts and genetic testing. Diagnosis can be difficult to establish in milder cases, especially if VLCFA concentration in plasma is not or only mildly elevated. We report on siblings in which initial measurement of plasma VLCFA did not indicate a peroxisomal disease. Nevertheless, cMRI showed a pattern typical for an inborn peroxisomal disease with cerebral and cerebellar leukencephalopathy, perisylvic polymicrogyria, and frontoparietal pachygyria. Repeated measurements of peroxisomal metabolites in plasma prompted by the cMRI findings showed values in the upper normal or mildly elevated range and led to further diagnostic steps. The diagnosis of a type III DBPD with a missense mutation (T15A) in the HSD17B4 gene, coding for D‐bifunctional protein (DBP), could be established. We conclude that a typical “peroxisomal pattern” in cMRI including cerebral and cerebellar leukencephalopathy, perisylvic polymicrogyria and pachygyria is a valuable clue to the diagnosis of DBPD, especially in cases with no or only very mild abnormalities in plasma.Keywords
This publication has 14 references indexed in Scilit:
- Cerebral MRI as a valuable diagnostic tool in Zellweger spectrum patientsJournal of Inherited Metabolic Disease, 2008
- A novel PEX12 mutation identified as the cause of a peroxisomal biogenesis disorder with mild clinical phenotype, mild biochemical abnormalities in fibroblasts and a mosaic catalase immunofluorescence pattern, even at 40 °CJournal of Human Genetics, 2007
- Peroxisomal multifunctional protein-2: The enzyme, the patients and the knockout mouse modelBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2006
- Pitfall in Metabolic Screening in a Patient with Fatal Peroxisomal β-Oxidation DefectNeuropediatrics, 2006
- Mutational Spectrum of d-Bifunctional Protein Deficiency and Structure-Based Genotype-Phenotype AnalysisThe American Journal of Human Genetics, 2006
- Clinical and biochemical spectrum of D‐bifunctional protein deficiencyAnnals of Neurology, 2005
- Peroxisomal disorders I: biochemistry and genetics of peroxisome biogenesis disordersClinical Genetics, 2004
- Metabolic and molecular basis of peroxisomal disorders: A reviewAmerican Journal of Medical Genetics Part A, 2004
- X-linked adrenoleukodystrophy with non-diagnostic plasma very long chain fatty acids.Journal of Neurology, Neurosurgery & Psychiatry, 1994
- Analysis of Peroxisomes in Lymphoblasts: Zellweger Syndrome and a Patient with a Deletion in Chromosome 7Pediatric Research, 1993